141 related articles for article (PubMed ID: 36892636)
1. Molecular comparison of concurrent components of high-grade dysplasia, adenocarcinoma, and sarcomatoid carcinoma in a case of sarcomatoid carcinoma of the gallbladder.
Hirose K; Omori Y; Ono Y; Mizukami Y; Kaneko Y; Maruyama T; Ohtani H; Furukawa T
Virchows Arch; 2023 Aug; 483(2):261-266. PubMed ID: 36892636
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.
Taskin OC; Akkas G; Memis B; Seven IE; Basturk O; Jang KT; Roa JC; Araya JC; Bellolio E; Losada H; Sarmiento J; Balci S; Pehlivanoglu B; Reid MD; Koshiol J; Adsay V
Virchows Arch; 2019 Jul; 475(1):59-66. PubMed ID: 31177317
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression.
Delahunt B; Eble JN; Nacey JN; Grebe SK
Anticancer Res; 1999; 19(5B):4279-83. PubMed ID: 10628387
[TBL] [Abstract][Full Text] [Related]
6. Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing.
Feng F; Cheng Q; Yang L; Zhang D; Ji S; Zhang Q; Lin Y; Li F; Xiong L; Liu C; Jiang X
Oncotarget; 2017 Jan; 8(3):5349-5360. PubMed ID: 28029662
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
Teh M; Wee A; Raju GC
Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.
Legan M; Luzar B; Marolt VF; Cor A
World J Gastroenterol; 2006 Jun; 12(21):3425-9. PubMed ID: 16733863
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
10. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.
Quan ZW; Wu K; Wang J; Shi W; Zhang Z; Merrell RC
J Am Coll Surg; 2001 Oct; 193(4):380-3. PubMed ID: 11584965
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.
Sciarra A; Missiaglia E; Trimech M; Melloul E; Brouland JP; Sempoux C; La Rosa S
Endocr Pathol; 2020 Mar; 31(1):84-93. PubMed ID: 31981075
[TBL] [Abstract][Full Text] [Related]
12. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
[TBL] [Abstract][Full Text] [Related]
13. Undifferentiated spindle cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and flow cytometric study of 11 cases.
Nishihara K; Tsuneyoshi M
Hum Pathol; 1993 Dec; 24(12):1298-305. PubMed ID: 8276377
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.
Kim K; Kim DH; Chae SW; Shin JH; Kim HJ; Do SI; Lee HJ; Koo JH; Pyo JS; Sohn JH
Pathol Oncol Res; 2014 Apr; 20(2):409-15. PubMed ID: 24178677
[TBL] [Abstract][Full Text] [Related]
15. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.
Wistuba II; Gazdar AF; Roa I; Albores-Saavedra J
Hum Pathol; 1996 Apr; 27(4):360-5. PubMed ID: 8617479
[TBL] [Abstract][Full Text] [Related]
16. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
17. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
